Ambrx Biopharma Inc. Deferred Revenue
Ambrx Biopharma Inc. had Deferred Revenue of $1.70 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2023-08-09
- 2023-06-30: Deferred Revenue $1.70M.
- 2023-03-31: Deferred Revenue $1.70M.
- 2022-12-31: Deferred Revenue $1.70M.
- 2022-06-30: Deferred Revenue $4.20M.
| Period end | Deferred Revenue |
|---|---|
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.70M 10-Q · filed 2023-08-09 |
| 2022-06-30 | $4.20M 6-K · filed 2022-08-29 |
| 2021-12-31 | $5.70M 10-K · filed 2023-03-30 |
| 2020-12-31 | $9.70M 20-F · filed 2022-04-26 |